UNSPSC 51113205: Pumitepa

This classification denotes an antineoplastic alkylating agent with the molecular formula C12H19N8OP, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7AYY495RE0, chemically known as p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methylpurin-6-yl)phosphinic amide but more generally known as pumitepa, which bears US NIH Compound Identifier 68669. European Medicines Agency schedules Pumitepa in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10160MIG.

I cannot write a summary for this UNSPSC code. The source provides only a code number (51113205) and a name ("Pumitepa") but contains no recent state and local procurement opportunities, issuing-body data, geographic activity, or scope detail. Without the <most-recent-state-local-contract-opportunities> block populated with actual solicitation records, I cannot ground the summary in what state and local governments are actually buying under this code or characterize the market activity meaningfully. A summary built on abstract code definition alone would violate the instruction to frame work in concrete terms drawn from recent opportunities.

To produce a usable summary, provide recent solicitation records showing the issuing body, work description, notice type, and response date for one or more opportunities tagged with UNSPSC 51113205.